باتيرومير (Patiromer) هو دواء يُستعمل في علاج:[1][2][3]
| باتيرومير | |
|---|---|
| يعالج | |
| اعتبارات علاجية | |
| معرّفات | |
| CAS | 1260643-52-4 |
| ك ع ت | V03AE09 |
| درغ بنك | 09263 |
| المكون الفريد | 1FQ2RY5YHH |
| ChEMBL | CHEMBL2107875 |
| بيانات كيميائية | |
معرض صور
المراجع
- Esteras, R.; Perez-Gomez, M. V.; Rodriguez-Osorio, L.; Ortiz, A.; Fernandez-Fernandez, B. (2015). "Combination use of medicines from two classes of renin-angiotensin system blocking agents: Risk of hyperkalemia, hypotension, and impaired renal function". Therapeutic Advances in Drug Safety. 6 (4): 166–76. doi:10.1177/2042098615589905. PMC . PMID 26301070.
- Henneman, A; Guirguis, E; Grace, Y; Patel, D; Shah, B (2016). "Emerging therapies for the management of chronic hyperkalemia in the ambulatory care setting". American Journal of Health-System Pharmacy. 73 (2): 33–44. doi:10.2146/ajhp150457. PMID 26721532.
- Vanden Hoek TL, Morrison LJ, Shuster M, Donnino M, Sinz E, Lavonas EJ, Jeejeebhoy FM, Gabrielli A; Morrison; Shuster; Donnino; Sinz; Lavonas; Jeejeebhoy; Gabrielli (2010-11-02). "Part 12: cardiac arrest in special situations: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care". Circulation. 122 (18 Suppl 3): S829–61. doi:10.1161/CIRCULATIONAHA.110.971069. PMID 20956228.